This study tests whether a combination of two antibodies (TMB-365 and TMB-380) given as an infusion every 8 weeks can keep HIV under control in people who are already suppressed on daily oral medication. About 88 adults with HIV will either switch to the antibody infusions or sta…
Phase: PHASE2 • Sponsor: TaiMed Biologics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC